Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

163.93 +0.85 (+0.52%)
Official Closing Price Updated: 4:10 PM EDT, Sep 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 479,860
Open 164.31
Bid (Size) 163.06 (1)
Ask (Size) 164.24 (1)
Prev. Close 163.08
Today's Range 161.99 - 164.31
52wk Range 71.51 - 166.04
Shares Outstanding 83,900,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AdaptHealth Stock Earns RS Rating Upgrade
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81. 
Via Investor's Business Daily
3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions come rolling in. That’s been precisely the case for Intuitive Surgical,... 
Via Talk Markets

Performance

YTD
+53.36%
+53.36%
1 Month
+8.62%
+8.62%
3 Month
+18.27%
+18.27%
6 Month
+18.93%
+18.93%
1 Year
+72.38%
+72.38%

More News

Read More
Bull Of The Day: Davita - Friday, September 6
Via Talk Markets
Top Medical Stocks To Hedge Against The September Effect
Via Talk Markets
Topics Economy
Exposures Interest Rates
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Key Takeaways From DaVita Analyst Ratings
Via Benzinga
6 Analysts Assess DaVita: What You Need To Know
Via Benzinga
DaVita (DVA) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
Via Benzinga
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
Via InvestorPlace
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Via Benzinga
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
Via Investor's Business Daily
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Via InvestorPlace
DaVita (DVA) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
Via InvestorPlace
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
Via The Motley Fool
Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
Via Investor's Business Daily
The Best Warren Buffett Stocks to Buy With $300 Right Now
Via The Motley Fool
3 Soaring, Highly-Ranked Value Stocks To Buy In April
Via Talk Markets
3 High-Dividend ETFs That Could Be Smart Investments Right Now
Via The Motley Fool
Topics Bonds ETFs
Exposures Debt Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.